tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Cleo Diagnostics Ltd Announces 2025 Annual General Meeting

Story Highlights
  • Cleo Diagnostics Ltd is a medical diagnostics company based in Melbourne.
  • The company will hold its 2025 Annual General Meeting on 24 November, encouraging digital engagement.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Cleo Diagnostics Ltd Announces 2025 Annual General Meeting

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

CLEO Diagnostics Ltd ( (AU:COV) ) just unveiled an announcement.

Cleo Diagnostics Ltd has announced its 2025 Annual General Meeting, scheduled for 24 November 2025, at RSM Australia Pty Ltd in Melbourne. The company will provide the Notice of Meeting electronically, encouraging shareholders to vote via directed proxy by 22 November 2025, reflecting a shift towards digital communication and engagement with stakeholders.

More about CLEO Diagnostics Ltd

Cleo Diagnostics Ltd operates in the medical diagnostics industry, focusing on the development and provision of diagnostic solutions. The company is based in Melbourne, Australia, and is listed on the Australian Securities Exchange under the ticker ASX:COV.

Average Trading Volume: 129,783

Technical Sentiment Signal: Strong Buy

Find detailed analytics on COV stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1